Helena Levander

Helena Levander appears in our data through filings on Recipharm AB shares, published by Finansinspektionen. Between 30 November 2017 and 15 February 2021, the trades on record add up to 4 filings.

Both buying and selling appear: 1 purchase worth €26k, against 1 sale worth €97k. The net balance comes to €70k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant. In 2021 alone, the filings show no purchases and 1 sale.

The latest filing, published on 16 February 2021, reports an open-market sale of €97k in Recipharm AB. The last purchase on record was published on 1 December 2017, which is 3,264 days ago. Filings reach the Finansinspektionen feed a median of 1 day after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.